Clinical Trials Browser

Phase 1 × Neoplasms × Metformin × Clear all

NCT03017833 2023-10-04

Sapanisertib and Metformin in Treating Patients With Advanced or Metastatic Relapsed or Refractory Cancers

Phase 1 Completed

Neoplasm Metastasis, Neoplasms

NCT01528046 2023-01-13

Metformin in Children With Relapsed or Refractory Solid Tumors

Phase 1 Completed

Brain Neoplasms, Neoplasms, Recurrence

NCT01442870 2017-05-09

Evaluation of Clinical Safety of Combining Metformin With Anticancer Chemotherapy

Phase 1 Completed

Neoplasms